Nymox Pharmaceutical
NYMX
#9275
Rank
A$27.37 M
Marketcap
Bahamas
Country
$0.30
Share price
0.00%
Change (1 day)
N/A
Change (1 year)

Nymox Pharmaceutical (NYMX) - Total liabilities

Total liabilities on the balance sheet as of June 2023 : A$4.72 M

According to Nymox Pharmaceutical's latest financial reports the company's total liabilities are A$4.72 M. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Nymox Pharmaceutical - Total liabilities on balance sheet (from 2001 to 2023)

Total liabilities by year

Year Total liabilities Change
2022-12-31A$3.09 M15.51%
2021-12-31A$2.68 M-6.03%
2020-12-31A$2.85 M-1.76%
2019-12-31A$2.9 M90.51%
2018-12-31A$1.52 M-46.65%
2017-12-31A$2.85 M-23.7%
2016-12-31A$3.74 M-21.3%
2015-12-31A$4.75 M-30.38%
2014-12-31A$6.83 M-13.23%
2013-12-31A$7.87 M-11.23%
2012-12-31A$8.87 M-21.39%
2011-12-31A$11.28 M-30.14%
2010-12-31A$16.15 M468.3%
2009-12-31A$2.84 M56.21%
2008-12-31A$1.81 M22.82%
2007-12-31A$1.48 M-45.53%
2006-12-31A$2.72 M-20.61%
2005-12-31A$3.42 M29.1%
2004-12-31A$2.65 M14.41%
2003-12-31A$2.31 M-11.2%
2002-12-31A$2.61 M78.35%
2001-12-31A$1.46 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
A$50.18 B 1,062,701.78%๐Ÿ‡บ๐Ÿ‡ธ USA
A$192.31 B 4,072,898.73%๐Ÿ‡บ๐Ÿ‡ธ USA
A$10.71 B 226,901.27%๐Ÿ‡บ๐Ÿ‡ธ USA
A$87.35 B 1,849,941.30%๐Ÿ‡บ๐Ÿ‡ธ USA
A$164.31 B 3,479,887.29%๐Ÿ‡บ๐Ÿ‡ธ USA